

Investing legends, Rentokil and AstraZeneca: The Companies and Markets Show
We begin with Mark Robinson who covers pest control business Rentokil (RTO) which saw a double digit surge in its share price after rumours of private-equity takeovers began swirling. It’s then on to this week’s cover story by James Norrington on the investing greats and how investors can apply their wisdom to their…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Investors' Chronicle
See all episodes →Similar episodes from other shows
More like Investors' Chronicle →
Counting the cost of Marks & Spencer’s cyber-attack, and AstraZeneca versus GSK

Will the vaccine value rally continue for investors?

Private equity’s workaround to buy law firms

Markets Round Up: Private Equity, ISAs, Rachel Reeves
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


